Johnson & Johnson to buy Shockwave Medical for US$12.5 billion
Add BT as a preferred source
JOHNSON & Johnson will buy medical device maker Shockwave Medical for about US$12.5 billion, the companies said on Friday (Apr 5), helping the healthcare conglomerate boost its portfolio of medical devices.
The California-based company makes a device which uses shockwaves to break down calcified plaque in heart vessels, similar to how kidney stones are treated.
Under the deal, J&J would pay US$335 per share in cash for the medical device maker. The offer price implies a 4.7% premium to Shockwave’s last close of US$319.99 on Thursday.
Shockwave, a company that makes devices to treat heart disease, has a market capitalisation of about US$12 billion, according to LSEG data. REUTERS
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Share with us your feedback on BT's products and services
TRENDING NOW
Singapore developer in limbo after Timor-Leste’s shock scrapping of major township project
On the board but frozen out: The Taib family feud tearing Sarawak construction giant apart
US-China summit: Trump sees ‘better’ ties, Xi warns over Taiwan, as talks conclude
That ‘cheap’ Malaysia condo could cost Singapore buyers far more than they think
